Navigation Links
BioPharm Insight Journalist Awarded Fellowship by Association of Health Care Journalists
Date:3/28/2013

Norwood, MA (PRWEB) March 28, 2013

Infinata’s BioPharm Insight™ is pleased to announce that Christine Livoti was selected to receive a fellowship to attend the National Press Foundation’s second annual program on “Obesity Issues 2013” in Aurora, Colo., April 28 – May 1. The program is sponsored by the Anschutz Health and Wellness Center at the University of Colorado Anschutz Medical Campus in Aurora, Colo.

Christine is a member of BioPharm Insight’s global team of investigative journalists who provide subscribers with a daily stream of proprietary intelligence predicting market-moving events 6-24 months in advance. BioPharm Insight offers the global biopharmaceutical community a unique combination of business intelligence, market analytics, key industry contacts, and award-winning independent investigative journalism.

She combines biopharmaceutical industry and business expertise. Christine has worked with NABsys, the Slater Technology Fund, and Landmark Ventures. She graduated from Brown University with a Bachelor’s and Master’s degree in Biology. Christine has published her research in tissue engineering. In addition to Obesity, Christine’s coverage areas include HCV, HIV, Diabetes, Melanoma, Basal Cell Carcinoma, Dermatology, Cosmetics/aesthetics, Sequencing Technology and Diagnostics.

Since 1976, the National Press Foundation has provided professional development opportunities to more than 5,000 editors, producers and reporters, helping them to better understand and explain the impact of public policy on readers and viewers.

Linda Topping Streitfeld, Director of Programs for the National Press Foundation, said, “Based on Christine’s experience in covering obesity and related issues, we know she will make an outstanding contribution to the program.”

This is Christine’s second fellowship win this year: In February she was chosen from among a record number of applicants to receive a Fell
'/>"/>

Source: PRWeb
Copyright©2012 Vocus, Inc.
All rights reserved

Page: 1 2 3

Related biology technology :

1. Keryx Biopharmaceuticals, Inc. Announces Upcoming Poster Presentations of Zerenex™ (Ferric Citrate) at the Upcoming American Society of Nephrology Kidney Week 2011 Annual Meeting
2. PDL BioPharma Announces Adjusted Conversion Rates for Its Convertible Notes
3. CeNeRx BioPharma Completes $4.85 Million Financing
4. PDL BioPharma Completes Regular Quarterly Dividend Payment
5. PAREXEL Introduces Executive Briefing Series on Proven Practices to Assist Emerging and Mid-size Biopharma in Achieving Better Outcomes
6. Inspiration Biopharmaceuticals Moves Corporate Headquarters to Cambridge, Massachusetts
7. Keryx Biopharmaceuticals to Present at JP Morgans 30th Annual Healthcare Conference
8. HealthCare Institute of New Jersey Releases 2011 Biopharmaceutical and Medical Technology Economic Impact Data
9. Sigma-Aldrich to Acquire BioReliance; Extending Its Reach into Biopharmaceutical Testing and Services
10. Galien Foundation Announces 2012 Awards Program For Best Biopharmaceutical Products and Best Medical Technology
11. Laureate Biopharma Appoints Les Mintzmyer, Vice President, Operations
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:10/20/2014)... Richardson, Texas (PRWEB) October 20, 2014 ... today announced that a team from Iowa State University ... * design contest. Using a Convey HC-2ex, the team’s ... than 14 times faster than the second place finisher. ... academic world embarked upon the month long challenge, using ...
(Date:10/20/2014)... Oct. 20, 2014  GenVec, Inc. (NASDAQ: GNVC ... , Ph.D., from its board of directors effective on October ... 2003, and served as its chairman from June 2006 to ... Nominating and Corporate Governance and Audit Committees of the board.  ... a decade of dedicated service to GenVec, and its stockholders," ...
(Date:10/20/2014)... 2014 Local veterinary surgeon, Dr. Tim ... study of donor stem cells for dogs with osteoarthritis. ... and has performed clinical stem cell therapy for 7 ... determine if a single injection of donor stem cells ... reduce pain and inflammation in the treated joints. ...
(Date:10/19/2014)... The Asia-Pacific Bromine Market report defines ... analysis and forecast of revenue. , Browse through ... report, to get an idea of the in-depth ... the segmentation in the Asia-Pacific bromine market, and ... , http://www.micromarketmonitor.com/market/asia-pacific-bromine-6741503144.html , Bromine is a ...
Breaking Biology Technology:Team from Iowa State Wins 2014 MemoCODE Design Contest Using Convey HC-2ex 2Team from Iowa State Wins 2014 MemoCODE Design Contest Using Convey HC-2ex 3Zola P. Horovitz To Retire From GenVec Board 2Cascade Veterinary Referral Center Seeks Candidates for an Investigational Study of Stem Cells for Dogs with Arthritis 2The Asia-Pacific Bromine Market is estimated to grow to $4,080.1 million by 2018 - New Report by MicroMarket Monitor 2The Asia-Pacific Bromine Market is estimated to grow to $4,080.1 million by 2018 - New Report by MicroMarket Monitor 3
... (OTC Bulletin Board: BNET) announced that notification was received,today ... System" has been granted by the Commonwealth of Australia,Patent ... The,official filing date is approved as November 8, 2001 ... date of November 8, 2021., This patent now ...
... N.J., Sept. 25 Osteotech, Inc.,(Nasdaq: OSTE ), ... for,regenerative medicine, announced today the appointment of Cato T.,Laurencin, ... joined the,Board of Directors effective September 24, 2008 and ... of the Board of Directors., Kenneth P. Fallon, ...
... Vanda,Pharmaceuticals Inc. (Nasdaq: VNDA ), a ... of clinical-stage product candidates,for central nervous system ... of Vanda Pharmaceuticals Inc. (the "Company") declared ... Right (a "Right") on each,outstanding share of ...
Cached Biology Technology:Bion Announces Approval of New Australian Patent for Low Oxygen Organic Waste Bioconversion for Livestock Waste Environmental Treatment 2Cato T. Laurencin, M.D., Ph.D. to Join Osteotech Board of Directors 2Vanda Pharmaceuticals Declares Dividend Distribution of Preferred Stock Purchase Rights 2Vanda Pharmaceuticals Declares Dividend Distribution of Preferred Stock Purchase Rights 3
(Date:10/18/2014)... Berlin, 19th October 2014 Psychological stress and stress-related ... for aging-related diseases, but the molecular mechanisms ... mechanisms may contribute to the development of ... treatments for these devastating diseases. This work ... Neuropsychopharmacology congress in Berlin., Now an international ...
(Date:10/17/2014)... of Copenhagen have shown for the first time how ... fibrosis patients, giving them the opportunity to get tremendous ... , The study also discovered the bacterial growth in ... halted or slowed down by the immune cells. The ... and helped "suffocate" the bacteria, forcing the bacteria to ...
(Date:10/16/2014)... how the bowel lining develops and, in the process, ... , The researchers produced evidence that stem cells are ... a feature of the bowel lining, and believe these ... controversial finding as scientists are still divided on the ... Chin Wee Tan and Professor Tony Burgess from the ...
Breaking Biology News(10 mins):Researchers find why depression and aging linked to increased disease risk 2Scientists opens black box on bacterial growth in cystic fibrosis lung infection 2Cryptic clues drive new theory of bowel cancer development 2
... Plant Science Center (PSC) have clarified a key epigenetic ... Arabidopsis protects cells from harmful DNA elements. Published in ... Genetics , the finding contributes to advancing our understanding ... plants and animals, opening the door to applications in ...
... Professor Cyrus Cooper, Professor of Rheumatology and Director ... has been awarded the Heberden Medal of the British ... Musculoskeletal Research Programme at the University of Southampton for ... 2003. His research programme has focused on ...
... WASHINGTONA bill in Oregon that would provide incentives to deliver ... the state,s residents and, at the same time, create hundreds ... according to a study released by Upstream Public Health in ... Health Impact Project, a collaboration of the Robert Wood Johnson ...
Cached Biology News:Discovery of DNA silencing mechanism reveals how plants protect their genome 2Oregon Farm to School bill would benefit health through job creation, study finds 2Oregon Farm to School bill would benefit health through job creation, study finds 3
... positive control for ChIP assays. Efficient fixation ... is a crucial step for the Chromatin-immunoprecipitation ... probably the most important parameter. Two major ... be taken into account: first, an excess ...
Mouse monoclonal [M2II-12] to MRP2 ( Abpromise for all tested applications). entrezGeneID: 1244 SwissProtID: Q92887...
The Programmable MP-5000P-F Power Supply can be applied for any Microfluidic application....
Rab GDP dissociation inhibitor beta...
Biology Products: